BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

PHARMAID

All Eps Dividend Board Agm Q1 Q2 Q3

PHARMAID 31-Jan-2022

(Q2 Un-audited): EPS was Tk. 5.53 for October-December 2021 as against Tk. 4.03 for October-December 2020; EPS was Tk. 10.69 for July-December 2021 as against Tk. 8.05 for July-December 2020. NOCFPS was Tk. 14.56 for July-December 2021 as against Tk. 13.89 for July-December 2020. NAV per share was Tk. 98.66 as on December 31, 2021 and Tk. 93.26 as on June 30, 2021.

(Q2 আন-অডিটেড): ইপিএস ছিল টাকা। অক্টোবর-ডিসেম্বর 2021-এর জন্য 5.53 টাকার বিপরীতে অক্টোবর-ডিসেম্বর 2020 এর জন্য 4.03; ইপিএস ছিল টাকা। জুলাই-ডিসেম্বর 2021-এর জন্য 10.69 টাকার বিপরীতে জুলাই-ডিসেম্বর 2020-এর জন্য 8.05। NOCFPS ছিল টাকা। জুলাই-ডিসেম্বর 2021-এর জন্য 14.56 টাকার বিপরীতে জুলাই-ডিসেম্বর 2020 এর জন্য 13.89। শেয়ার প্রতি NAV ছিল টাকা। 31 ডিসেম্বর, 2021 তারিখে 98.66 এবং টাকা 30 জুন, 2021 অনুযায়ী 93.26।

PHARMAID 15-Nov-2021

(Q1 Un-audited): EPS was Tk. 5.15 for July-September 2021 as against Tk. 4.01 for July-September 2020; NOCFPS was Tk. 3.37 for July-September 2021 as against Tk. 1.94 for July-September 2020. NAV per share was Tk. 98.29 as on September 30, 2021 and Tk. 93.26 as on June 30, 2021.

PHARMAID 10-Nov-2021

The Board of Directors has recommended 50% cash dividend for the year ended on June 30, 2021. Date of AGM: 30.12.2021, Time: 11:30 AM, Venue: Digital Platform. Record date: 07.12.2021. The Company has reported EPS of Tk. 16.11, NAV per share of Tk. 93.26 and NOCFPS of Tk. 10.07 for the year ended on June 30, 2021 as against Tk. 16.82, Tk. 82.54 and Tk. 13.04 respectively for the same period of the previous year.

PHARMAID 02-May-2021

(Q3 Un-audited): EPS was Tk. 4.12 for January-March 2021 as against Tk. 4.34 for January-March 2020; EPS was Tk. 12.17 for July 2020-March 2021 as against Tk. 14.31 for July 2019-March 2020. NOCFPS was Tk. 9.97 for July 2020-March 2021 as against Tk. 11.94 for July 2019-March 2020. NAV per share was Tk. 89.45 as on March 31, 2021 and Tk. 82.54 as on June 30, 2020. They have informed that EPS decreased due to increase of expenses in connection with COVID-19.

PHARMAID 31-Jan-2021

(Q2 Un-audited): EPS was Tk. 4.03 for October-December 2020 as against Tk. 5.15 for October-December 2019; EPS was Tk. 8.05 for July-December 2020 as against Tk. 9.77 for July-December 2019. NOCFPS was Tk. 13.89 for July-December 2020 as against Tk. 13.79 for July-December 2019. NAV per share was Tk. 85.41 as on December 31, 2020 and Tk. 82.54 as on June 30, 2020.

PHARMAID 15-Nov-2020

(Q1 Un-audited): EPS was Tk. 4.01 for July-September 2020 as against Tk. 4.63 for July-September 2019; NOCFPS was Tk. 1.94 for July-September 2020 as against Tk. 6.20 for July-September 2019. NAV per share was Tk. 86.47 as on September 30, 2020 and Tk. 82.54 as on June 30, 2020.

PHARMAID 10-Nov-2020

The Board of Directors has recommended 50% cash dividend for the year ended on June 30, 2020. Date of AGM: 24.12.2020, Time: 11:30 AM, Venue: Virtual Platform. Record date: 07.12.2020 The Company has reported EPS of Tk. 16.82, NAV per share of Tk. 82.54 and NOCFPS of Tk. 13.04 for the year ended on June 30, 2020 as against Tk. 15.48, Tk. 71.08 and Tk. 8.05 respectively for the same period of the previous year.

PHARMAID 25-Jun-2020

(Q3 Un-audited): EPS was Tk. 4.33 for January-March 2020 as against Tk. 4.15 for January-March 2019; EPS was Tk. 14.30 for July 2019-March 2020 as against Tk. 13.46 for July 2018-March 2019. NOCFPS was Tk. 11.94 for July 2019-March 2020 as against Tk. 7.82 for July 2018-March 2019. NAV per share was Tk. 80.14 as on March 31, 2020 and Tk. 71.08 as on June 30, 2019.

PHARMAID 30-Jan-2020

(Continuation news of PHARMAID): It is to be noted that NAV per share was increased due to increase of retained earnings. EPS was increased due to increase of sales and Net Profit and NOCFPS was increased due to increase of Sales and Collection than the previous quarter. (end)

PHARMAID 30-Jan-2020

(Q2 Un-audited): EPS was Tk. 5.15 for October-December 2019 as against Tk. 4.67 for October-December 2018; EPS was Tk. 9.77 for July-December 2019 as against Tk. 9.31 for July-December 2018. NOCFPS was Tk. 13.79 for July-December 2019 as against Tk. 11.00 for July-December 2018. NAV per share was Tk. 75.72 as on December 31, 2019 and Tk. 71.08 as on June 30, 2019. (cont.)

Previous Next page